Skip to main content
SYNAIRGEN PLC logo

SYNAIRGEN PLC — Investor Relations & Filings

Ticker · SNG ISIN · GB00B0381Z20 LEI · 213800IMMTOPPDF8HD24 IL Manufacturing
Open in API
Filings indexed 379 across all filing types
Latest filing 2022-09-05 Regulatory Filings
Country GB United Kingdom
Listing IL SNG

About SYNAIRGEN PLC

https://www.synairgen.com/

Synairgen PLC is a clinical-stage biotechnology company focused on the discovery and development of treatments for severe respiratory diseases. The company's primary focus is its lead investigative candidate, SNG001, an inhaled formulation of interferon-beta (IFN-β). SNG001 is being developed as a potential host-directed, broad-spectrum antiviral therapy delivered directly to the lungs. This approach aims to treat hospitalized patients with severe viral lung infections caused by a range of pathogens, including influenza, RSV, and coronaviruses.

Recent filings

Filing Released Lang Actions
Company Announce Collaboration on UNIVERSAL Trial
Regulatory Filings Classification · 99% confidence The document starts with 'RNS Number : 1893Y' and contains information typical of a regulatory news service announcement, including company updates, collaboration news, and contact details for brokers and media relations. The footer explicitly states, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This indicates it is a general regulatory announcement that does not fit into the specific categories like 10-K, ER, or DIV. Since it is a general announcement distributed via the RNS system but explicitly marked as non-regulatory news (Reach), the most appropriate fallback category is Regulatory Filings (RNS), as it serves as the general announcement channel.
2022-09-05 English
Grant of Options
Director's Dealing Classification · 98% confidence The document is an RNS announcement dated July 6, 2022, detailing the 'Grant of Options' over ordinary shares to Directors and Persons Discharging Managerial Responsibilities (PDMRs). This type of filing reports personal share transactions (or the granting of rights to shares) by company executives and directors. This directly aligns with the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). Although it involves options, the core purpose is reporting insider transaction activity.
2022-07-06 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly announces the 'Results of Annual General Meeting' held on June 30, 2022, stating that 'All resolutions proposed at its Annual General Meeting were passed.' This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, or in this case, the results thereof. Although it mentions voting results, the primary context is the AGM event itself, making AGM-R a better fit than DVA (Declaration of Voting Results & Voting Rights Announcements), which is usually for the formal declaration of results after the fact, whereas this is the announcement related to the meeting proceedings. Given the content focuses on the meeting's outcome, AGM-R is the most precise classification.
2022-06-30 English
Group of companies' accounts made up to 2021-12-31
Regulatory Filings
2022-06-30 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1925 characters) and contains an RNS Number (0263Q) and references the London Stock Exchange and the Financial Conduct Authority (FCA). The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific type of regulatory market announcement. Since it is a brief, specific regulatory notice that doesn't fit the definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder votes (DVA), the most appropriate classification is the general regulatory announcement category, RNS. It is not an announcement *about* a report, but a direct regulatory update.
2022-06-23 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1908 characters) and contains an RNS Number (0246Q) and mentions the London Stock Exchange. The content describes a 'Price Monitoring Extension' for a security, which is a specific, brief operational announcement related to trading mechanics, not a comprehensive financial report or a standard regulatory filing like 10-K or ER. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIV, DIRS, ER, etc.), the most appropriate fallback category is Regulatory Filings (RNS).
2022-06-23 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.